INS and Hypoglycemia: The definition of intense therapy has changed in the recent decade with the availability of new antihyperglycemic medications that have a lower risk of hypoglycemia in comparison to sulfonylureas and insulin and provide additional alternatives for combination therapy targeted at improving glycemic control [21].